Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Gemcitabine vs Gemcitabine + TS-1 Chemoradiation in Pancreatic Cancer
NCT02754180Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Mar 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in pancreatic ductal adenocarcinoma (PDAC), sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
tegafur
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT02754180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02754180.